Soung, J., Ständer, S., Gutermuth, J., Pau-Charles, I., Dawson, Z., Yang, F. E., . . . Stein-Gold, L. Lebrikizumab monotherapy impacts on quality of life scores through improved itch and sleep interference in two Phase 3 trials. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSoung, Jennifer, et al. Lebrikizumab Monotherapy Impacts on Quality of Life Scores Through Improved Itch and Sleep Interference in Two Phase 3 Trials. Taylor & Francis Group.
MLA (9th ed.) CitationSoung, Jennifer, et al. Lebrikizumab Monotherapy Impacts on Quality of Life Scores Through Improved Itch and Sleep Interference in Two Phase 3 Trials. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.